Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis
NCT00291915 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2006-02-15
Summary
Evaluation of two treatment modalities in early potentially severe early arthritis ( Methotrexate alone or in combination with adalimumab)
Conditions
Interventions
- DRUG
- DRUG
-
Methotrexate
Sponsors & Collaborators
-
Goupe d'Etudes et de Recherche Clinique En Rhumatologie
lead OTHER
Principal Investigators
-
Maxime DOUGADOS, MD · Hopital Cochin Paris FRance
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-05-31
- Completion
- 2007-03-31
Countries
- France
Study Locations
More Related Trials
-
An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
NCT02187055 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.
NCT00195702 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01519791 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis
NCT00299104 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis
NCT02288520 ·Status: COMPLETED
-
Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
NCT01142726 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis
NCT00195663 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)
NCT02814175 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis
NCT00299130 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice
NCT01736189 ·Status: COMPLETED
-
Remission and Joint Damage Progression in Early Rheumatoid Arthritis
NCT00122382 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT02097264 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
NCT01162421 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT01909427 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid Arthritis
NCT01034137 ·Status: COMPLETED ·Phase: PHASE3
-
Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy
NCT02886728 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)
NCT01569152 ·Status: TERMINATED ·Phase: PHASE2
-
A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)
NCT02706951 ·Status: COMPLETED ·Phase: PHASE3
-
Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
NCT02889796 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT01399697 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
NCT00345748 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01521923 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
NCT01500278 ·Status: COMPLETED ·Phase: PHASE4
-
Methotrexate and Metformin in Rheumatoid Arthritis Patients
NCT04196868 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate
NCT02706873 ·Status: COMPLETED ·Phase: PHASE3